The entry inhibitor DS003 (BMS-599793): a BMS-806 analogue, provides superior activity as a pre-exposure prophylaxis candidate
Article in AIDS (June 2021)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Molecular Signatures of a TLR4 Agonist-Adjuvanted HIV-1 Vaccine Candidate in Humans
Article in Frontiers in Immunology (February 2018)
Differential immune responses to HIV-1 envelope protein induced by liposomal adjuvant formulations containing monophosphoryl lipid A with or without QS21
Article in Vaccine (September 2015)